Evidence map›Paper›PMID 32670859›Full record

ArticleFrontiers in oncology2020

Silencing SCAMP1-TV2 Inhibited the Malignant Biological Behaviors of Breast Cancer Cells by Interaction With PUM2 to Facilitate INSM1 mRNA Degradation.

Wei Tao, Jun Ma, Jian Zheng, Xiaobai Liu, Yunhui Liu, Xuelei Ruan, Shuyuan Shen, Lianqi Shao, Jiajia Chen, Yixue Xue

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Cancers · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. INSM1 promotes breast carcinogenesis by regulating C-MYC.American journal of cancer research · 2023
    Article
  11. Article
  12. Long Noncoding RNAMolecular and cellular biology · 2022
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wei TaoDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Jun MaDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Jian ZhengDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Xiaobai LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Yunhui LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Xuelei RuanDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Shuyuan ShenDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Lianqi ShaoDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Jiajia ChenDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Yixue XueDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerlncRNAmRNA degradationPUM2RNA binding protein (RBP)SCAMP1-TV2

Identifiers

PMID32670859
PMCPMC7326047
OpenAlexW3029505615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.